Your browser doesn't support javascript.
loading
TGF-ß receptor I inhibitor enhances response to enzalutamide in a pre-clinical model of advanced prostate cancer.
Paller, Channing; Pu, Hong; Begemann, Diane E; Wade, Cameron A; Hensley, Patrick J; Kyprianou, Natasha.
Afiliação
  • Paller C; The Johns Hopkins Kimmel Cancer Center and Department of Medicine, Johns Hopkins University, Baltimore, Maryland.
  • Pu H; Department of Urology, University of Kentucky College of Medicine, Lexington, Kentucky.
  • Begemann DE; Department of Toxicology and Cancer Biology, University of Kentucky College of Medicine, Lexington, Kentucky.
  • Wade CA; Department of Urology, University of Kentucky College of Medicine, Lexington, Kentucky.
  • Hensley PJ; Department of Urology, University of Kentucky College of Medicine, Lexington, Kentucky.
  • Kyprianou N; Department of Urology, University of Kentucky College of Medicine, Lexington, Kentucky.
Prostate ; 79(1): 31-43, 2019 01.
Article em En | MEDLINE | ID: mdl-30155899
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Feniltioidantoína / Neoplasias da Próstata / Pirazóis / Quinolinas / Transição Epitelial-Mesenquimal / Receptor do Fator de Crescimento Transformador beta Tipo I / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Prostate Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Feniltioidantoína / Neoplasias da Próstata / Pirazóis / Quinolinas / Transição Epitelial-Mesenquimal / Receptor do Fator de Crescimento Transformador beta Tipo I / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Prostate Ano de publicação: 2019 Tipo de documento: Article